DXC director Anthony Gonzalez sells 12,300 shares at ~$13.78 each

Anthony Gonzalez, a director of DXC Technology Co (DXC), reported multiple sales of the issuer's common stock on 08/13/2025.

Rhea-AI Filing Summary

Anthony Gonzalez, a director of DXC Technology Co (DXC), reported multiple sales of the issuer's common stock on 08/13/2025. The Form 4 shows four separate disposition transactions totaling 12,300 shares sold at prices ranging from $13.78 to $13.79. The filing notes that the reported beneficial ownership amounts include unvested restricted stock units. After the reported sales, Mr. Gonzalez's beneficial ownership in DXC is shown as 34,300 shares.

Positive

• Disclosure compliance: The reporting person filed a timely Form 4 detailing multiple transactions and included a signed attorney-in-fact signature.
• Clarity on unvested units: The filing explicitly states that reported amounts include unvested Restricted Stock Units, improving transparency about remaining ownership.

Negative

• Insider selling activity: The director sold 12,300 shares on 08/13/2025, reducing beneficial ownership from 40,800 to 34,300 shares.
• No 10b5-1 plan indicated: The form does not mark that the transactions were made pursuant to a trading plan intended to satisfy Rule 10b5-1(c), which could raise questions about timing (though no improper conduct is alleged in the filing).

Insights

Corporate Governance Expert

TL;DR: Director executed routine stock sales reducing beneficial ownership to 34,300 shares; transactions appear ordinary disposition.

The Form 4 discloses four sale transactions executed on 08/13/2025 by director Anthony Gonzalez, amounting to 12,300 shares disposed at prices between $13.78 and $13.79. The filing explicitly states reported amounts include unvested restricted stock units, which is important for interpreting remaining ownership. No option exercises, grants, or derivative transactions were reported. As disclosed, these are individual sales by a reporting person and the filing does not reference any new agreements, policy-based plan, or unusual execution detail.

Securities Analyst

TL;DR: Insider sales of 12,300 shares on a single date; impact appears routine and non-material absent other context.

The disclosure lists four sales (codes "S") on 08/13/2025 at prices of $13.78, $13.781, $13.785, and $13.79, reducing reported beneficial ownership from 40,800 to 34,300 shares (amounts include unvested RSUs). There is no indication of derivative activity or a 10b5-1 plan checked on the form. From an investor reporting perspective, this is a standard Section 16 disclosure of insider dispositions without additional contextual items such as large, single-block sales or related-party transactions noted in the filing.

Insider Trade Summary

Net Seller: 12,300 shares

Net Sell 4 txns

Insider Gonzalez Anthony

Role Director

Sold 12,300 shs ($170K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,800	$13.78	$80K
Sale	Common Stock	4,348	$13.781	$60K
Sale	Common Stock	6	$13.785	$82.71
Sale	Common Stock	2,146	$13.79	$30K

Holdings After Transaction: Common Stock — 34,300 shares (Direct)

Footnotes (1)

1. F1. Amount reported includes unvested Restricted Stock Units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did DXC director Anthony Gonzalez report on Form 4 (DXC)?

The Form 4 reports four sales on 08/13/2025 totaling 12,300 shares disposed at prices between $13.78 and $13.79.

How many DXC shares does Anthony Gonzalez beneficially own after the reported trades?

Following the reported transactions, the filing shows Mr. Gonzalez beneficially owns 34,300 shares (amounts include unvested RSUs).

Were any derivative securities or option transactions reported by the reporting person?

No. Table II for derivative securities shows no reported acquisitions or dispositions; only common stock sales appear in Table I.

Does the Form 4 indicate the sales were made under a Rule 10b5-1 trading plan?

No. The check box indicating transactions pursuant to a 10b5-1(c) plan is not marked in the provided filing content.

Who signed the Form 4 on behalf of the reporting person?

The signature block shows Matt Fawcett, Attorney-in-Fact dated 08/15/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/15/2025 - 06:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gonzalez Anthony

(Last) (First) (Middle)

20408 BASHAN DRIVE

SUITE 231

(Street)

ASHBURN VA 20147

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DXC Technology Co [ DXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		S		5,800	D	$13.78	40,800(1)	D
Common Stock	08/13/2025		S		4,348	D	$13.781	36,452(1)	D
Common Stock	08/13/2025		S		6	D	$13.785	36,446(1)	D
Common Stock	08/13/2025		S		2,146	D	$13.79	34,300(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Amount reported includes unvested Restricted Stock Units.

Remarks:

	Matt Fawcett, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.